首页> 外文期刊>The Indian journal of medical research. >Introducing pentavalent vaccine in EPI in India: issues involved
【24h】

Introducing pentavalent vaccine in EPI in India: issues involved

机译:在印度的EPI中引入五价疫苗:涉及的问题

获取原文
获取原文并翻译 | 示例
           

摘要

The Editorial by Lone and Puliyel1 contains several factual errors. It exhibits a time warp, citing old information but not its new details and a disregard for truth by arguments taken out of context. It contains statements that have been disproved. The idea of pentavalent vaccine has 'technical' elements - the epidemiological need to introduce hepatitis B (HB) vaccine and Haemophilus influenzae b (Hib) vaccine in the Universal Immunisation Programme (UIP) and a 'programmatic' element ? the option to give them separately from diphtheria, whole-cell-pertussis (wP) and tetanus (DwPT) vaccine (9 injections per child) versus in combination (pentavalent vaccine) to simplify the vaccination procedure (3 injections).
机译:Lone和Puliyel1的《社论》包含一些事实错误。它表现出时间扭曲,引用了旧信息,但未引用新信息,并且由于上下文无关的争论而无视真理。它包含已被拒绝的语句。五价疫苗的想法具有“技术性”要素-流行病学需要在通用免疫计划(UIP)中引入乙型肝炎(HB)疫苗和流感嗜血杆菌b(Hib)疫苗,并且具有“程序性”要素?可选择将它们与白喉,全细胞百日咳(wP)和破伤风(DwPT)疫苗分开接种(每个孩子9针),而不是联合使用(五价疫苗)以简化接种程序(3针)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号